Moderna vaccine shows 94.1% efficacy in trial: Study

Results from the primary analysis of the ongoing phase 3 clinical trial of US biotechnology company Moderna's Covid-19 vaccine have revealed 94.1 per cent efficacy of the therapeutic in preventing symptomatic infections and severe illness, according to a peer-reviewed study.

from World News Headlines, Latest International News, World Breaking News - Times of India https://ift.tt/3n334dk

Comments

Popular posts from this blog

National Equestrian Competition: 14 साल के अमन राज सिंह ने जीती नेशनल घुड़सवारी प्रतियोगिता

Did Donald Trump confirm Harry-Meghan divorce rumors? Here's what happened

Imran steps down as PTI chief, picks aide Gohar Khan as 'interim' successor